Document:

EX-10.1

 Exhibit 10.1 

October 14, 2021 
 [Name and address of
warrant holder] 
  

	 	Re:	 Exercise Price Reset Offer of Common Stock Purchase Warrants 

To Whom It May Concern: 
 Myomo, Inc. (the
“Company”) is pleased to offer to you the opportunity to reprice the Exercise Price of all of the Common Stock purchase warrants of the Company (the “Warrants”) currently held by you (the “Holder”)
and as set forth on your signature page attached hereto. The shares of common stock, par value $0.0001 (“Common Stock”), underlying the Warrants (“Warrant Shares”) have been registered pursuant to a registration
statement on Form S-1 and Form S-1MEF (File Nos. 333-235538 and 333-236360) (the
“Registration Statement”). The Registration Statement is currently effective and, upon exercise of the Warrants, will, to the Company’s knowledge, be effective for the issuance of the Warrant Shares. Capitalized terms not
otherwise defined herein shall have the meanings set forth in the Warrants.  
 In consideration for cash exercising all of the Warrants
held by you on or before 9:00 a.m. (New York City time) on October 15, 2021 (the “Warrant Exercise”), the Company hereby offers you a reduced exercise price of the Reprice Warrants to $5.00. Notwithstanding anything
herein to the contrary, in the event the Warrant Exercise would otherwise cause the Holder to exceed the beneficial ownership limitations (“Beneficial Ownership Limitation”) set forth in Section 1(f) of the Warrants, the
Company shall only issue such number of Warrant Shares to the Holder that would not cause the Holder to exceed the maximum number of Warrant Shares permitted thereunder with the balance to be held in abeyance until notice from the Holder that the
balance (or portion thereof) may be issued in compliance with such limitations, which abeyance shall be evidenced through the Warrant which shall be deemed prepaid thereafter, and exercised pursuant to a Notice of Exercise in the Warrant (provided
no additional exercise price shall be payable). 
 The Holder may accept this offer by signing this letter below, with such acceptance
constituting the Holder’s exercise of the number of Warrants as set forth on the Holder’s signature page attached hereto for an aggregate exercise price as set forth on the Holder’s signature page hereto (the “Aggregate
Exercise Price”) on or before 9:00 a.m. (New York City time) on October 15, 2021. 
 Additionally, the Company agrees to the
representations, warranties and covenants set forth on Annex A attached hereto. Holder represents and warrants that, as of the date hereof it is an “accredited investor” as defined in Rule 501 of the Securities Act.

If this offer is accepted and this letter agreement is executed and delivered to the Company on or before 9:00 a.m. (New York City time) on
October 15, 2021, the Company shall file a Current Report on Form 8-K with the Securities and Exchange Commission disclosing all material terms of the transactions contemplated hereunder, including this
letter agreement as an exhibit thereto (the “8-K Filing”) on or before 9:30 a.m. (New York City time) on October 15, 2021. From and after the issuance of the 8-K Filing, the Company represents to the Holder that it shall have publicly disclosed all material, non-public information delivered to the Holder by the Company or any of
its officers, directors, employees or agents 

 
in connection with the transactions contemplated hereby. In addition, effective upon the issuance of the 8-K Filing, the Company acknowledges and agrees
that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company or any of its officers, directors, agents, employees or Affiliates on the one hand, and the Holder or any of its Affiliates on
the other hand, shall terminate. From and after the issuance of the 8-K Filing, the Company represents to the Holder that none of the Company’s directors, officers, employees or agents will provide the
Holder with any material, nonpublic information that is not disclosed in the 8-K Filing. 
 The
Company represents, warrants and covenants that, upon acceptance of this offer, all of the Warrant Shares being exercised shall be delivered electronically through the Depository Trust Company within one (1) Trading Day of the date the Company
receives the Aggregate Exercise Price (or, with respect to shares of Common Stock that would otherwise be in excess of the Beneficial Ownership Limitation, within one (1) Business Day of the date the Company is notified by Holder that its
ownership is less than the Beneficial Ownership Limitation). Except as set forth herein, the terms of the Warrants, including but not limited to the obligations to deliver the Warrant Shares, shall remain in effect as if the acceptance of this offer
was a formal exercise notice under the Warrants. 
 The Company acknowledges and agrees that the obligations of the Holder under this letter
agreement are several and not joint with the obligations of any other holder of Common Stock purchase warrants of the Company (each, an “Other Holder”) under any other agreement related to the exercise of such warrants
(“Other Warrant Exercise Agreement”), and the Holder shall not be responsible in any way for the performance of the obligations of any Other Holder or under any such Other Warrant Exercise Agreement. Nothing contained in this letter
agreement, and no action taken by the Holder pursuant hereto, shall be deemed to constitute the Holder and the Other Holders as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Holder and
the Other Holders are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this letter agreement and the Company acknowledges that the Holder and the Other Holders are not acting in concert
or as a group with respect to such obligations or the transactions contemplated by this letter agreement or any Other Warrant Exercise Agreement. The Company and the Holder confirm that the Holder has independently participated in the negotiation of
the transactions contemplated hereby with the advice of its own counsel and advisors. The Holder shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this letter agreement, and
it shall not be necessary for any Other Holder to be joined as an additional party in any proceeding for such purpose. 
 The Company hereby
represents and warrants as of the date hereof and covenants and agrees from and after the date hereof until 60 Trading Days after the date hereof, that none of the terms offered to any Other Holder with respect to any Other Warrant Exercise
Agreement (or any amendment, modification or waiver thereof), is or will be more favorable to such Other Holder than those of the Holder and this letter agreement. If, and whenever on or after the date hereof until 60 Trading Days after the date
hereof, the Company enters into an Other Warrant Exercise Agreement, then (i) the Company shall provide notice thereof to the Holder promptly following the occurrence thereof and (ii) the terms and conditions of this letter agreement shall
be, without any further action by the Holder or the Company, automatically amended and modified in an economically and legally equivalent manner such that the Holder shall receive the benefit of the more favorable terms and/or conditions (as the
case may be) set forth in such Other Warrant Exercise Agreement (including the issuance of additional Warrant Shares), provided that 

  
 2 

 
upon written notice to the Company at any time the Holder may elect not to accept the benefit of any such amended or modified term or condition, in which event the term or condition contained in
this letter agreement shall apply to the Holder as it was in effect immediately prior to such amendment or modification as if such amendment or modification never occurred with respect to the Holder. The provisions of this paragraph shall apply
similarly and equally to each Other Warrant Exercise Agreement. 
 Each party shall pay the fees and expenses of its advisers, counsel,
accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this letter agreement. The Company shall pay all transfer agent fees, stamp taxes
and other taxes and duties levied in connection with the delivery of any Warrant Shares. This letter agreement shall be governed by the laws of the State of New York without regard to the principles of conflicts of law thereof. 

*************** 

  
 3 

 To accept this offer, Holder must counter execute this letter agreement and return the fully
executed letter agreement to the Company at e-mail: _________, attention: _________, on or before 9:00 am (New York City time) on October 15, 2021. 

Please do not hesitate to call me if you have any questions. 

 

			
	Sincerely yours,
	
	MYOMO, INC.
		
	By:	 	
                 

	Name:
	Title:

  
 4 

 Accepted and Agreed to: 

Name of Holder: ________________________________________________________ 

Signature of Authorized Signatory of Holder: _________________________________ 

Name of Authorized Signatory: _______________________________________________ 

Title of Authorized Signatory: ________________________________________________ 

Warrant Shares: _____________________ 
 Number of Warrants being
exercised contemporaneously with signing this letter: _____________ 
 Aggregate Exercise Price of the Warrants being exercised contemporaneously with
signing this letter: $___________________ 
 DTC Instructions: 

The Warrant Shares shall be delivered to the following DWAC Account Number: 

 

			
	Broker Name:	 	                                      
                                         
                 
		
	Broker DTC DWAC #:	 	                                      
                                         
                 
		
	Broker Contact:	 	                                      
                                         
                 
		
	Account #:	 	                                      
                                         
                 

  
 5 

 Annex A – Representations, Warranties and Covenants 

Representations, Warranties and Covenants of the Company. The Company hereby makes the following representations and warranties to the
Holder: 
 (a) Registration Statement. The Warrant Shares are registered for issuance on a Registration Statement on
Form S-1 and Form S-1MEF (File Nos. 333-235538 and 333-236360) (the “Registration
Statement”) and the Company knows of no reason why such registration statement shall not remain effective for the foreseeable future. The Company shall use commercially reasonable efforts to keep the Registration Statement effective and
available for use by the Holder until all Warrant Shares underlying the Warrants are sold by the Holder. 
 (b)
Authorization; Enforcement. The Company will have the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this letter agreement and otherwise to carry out its obligations hereunder and
thereunder. The execution and delivery of this letter agreement by the Company and the consummation by the Company of the transactions contemplated hereby will be duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, its board of directors or its stockholders in connection therewith. This letter agreement has been duly executed by the Company and, when delivered in accordance with the terms hereof, will constitute the valid and
binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and
contribution provisions may be limited by applicable law. 
 (c) No Conflicts. The execution, delivery and performance
of this letter agreement by the Company and the consummation by the Company of the transactions contemplated hereby do not and will not: (i) conflict with or violate any provision of the Company’s certificate of incorporation, bylaws or
other organizational or charter documents; or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company in connection with, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any material agreement, credit facility, debt or other material
instrument (evidencing Company debt or otherwise) or other material understanding to which such Company is a party or by which any property or asset of the Company is bound or affected, other than for which a waiver has been obtained by the Company;
or (iii) subject to Section (d) below, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company is subject
(including federal and state securities laws and regulations), or by which any property or asset of the Company is bound or affected. 

(d) NYSE American Corporate Governance. The transactions contemplated under this letter agreement, comply with all rules
of NYSE American. 

  
 6 

 (e) Subsequent Equity Sales. From the date hereof until the 30 day
anniversary of the date hereof, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file
any registration statement or any amendment or supplement thereto, in each case other than a registration statement on Form S-8. Notwithstanding the foregoing, this Section (e) shall not apply in respect
of an Exempt Issuance. As used herein, “Exempt Issuance” means the issuance of (a) shares of Common Stock, options, restricted stock, restricted stock units or other equity awards to employees, officers or directors of the Company
pursuant to any stock or option plan duly adopted for such purpose, which issuance has been approved by the Company’s compensation committee, (b) securities exercisable or exchangeable for or convertible into shares of Common Stock issued
and outstanding on the date of this letter, provided that such securities have not been amended since the date of this letter to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such
securities (except for such decreases in exercise, exchange or conversion price in accordance with the terms of such securities) or to extend the term of such securities, (c) securities issued pursuant to acquisitions, joint ventures,
collaborations or similar strategic transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as “restricted securities” (as defined in Rule 144) and carry no registration
rights that require or permit the filing of any registration statement in connection therewith until the 30 day anniversary of the date hereof, and provided that any such issuance shall only be to a Person (or to the equity holders of a Person)
which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but
shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities. As used herein, “Common Stock Equivalents” means any
securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time
convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock. 

  
 7Exhibit 10.1

 

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT
AGREEMENT (this “Agreement”) is entered into as of October 13, 2021 (the “Effective
Date”) by and between Auddia Inc. a Delaware corporation (the “Company”) and Michael Lawless
(“Executive”). This agreement supersedes and replaces the previous employment agreement dated February 6, 2012 in
its entirety.

 

RECITALS

 

A.               
The Company considers it essential to its best interests to procure the employment of Executive by the Company from and after the
date hereof.

 

B.                
Executive agrees to such employment on the terms hereinafter set forth in this Agreement.

 

AGREEMENT

 

NOW, THEREFORE, in consideration
of the promises and mutual covenants contained herein and for other good and valuable consideration, the parties agree as follows:

 

1.       Definitions.
For purposes of this Agreement only (unless specified to the contrary), the following terms shall have the meanings set forth below:

 

“Affiliate”
means, with respect to any individual or entity, (i) such individual’s spouse and lineal relations (whether natural or adopted)
and any trust formed and maintained solely for the benefit of such individual or such individual’s spouse or lineal relations and
(ii) any person or entity controlling, controlled by or under common control with such individual or entity, whether by ownership
of voting securities, by contract or otherwise.

 

“Cause”
means any of the following:

 

(i)                
Executive’s willful and continued failure substantially to perform Executive’s duties in accordance with the Company’s
bylaws and written policies, and as directed by the Company Board; provided, however, that “Cause” shall not
be present under this clause unless (1) the Company shall have given Executive written notice specifying in reasonable detail
the event or circumstances constituting Cause under this clause, and (2) Executive fails to cure such event or circumstances within
thirty (30) days after such notice;

 

(ii)             
Executive’s material and willful breach of this Agreement, the Company’s Operating Agreement, the Proprietary Information
Agreement or any confidentiality or proprietary rights provisions contained herein or in separate agreements among Executive and the Company;
provided, however, that “Cause” shall not be present under this clause unless (1) the Company shall
have given Executive written notice specifying in reasonable detail the event or circumstances constituting Cause under this clause, and
(2) Executive fails to cure such event or circumstances within thirty (30) days after such notice;

 

(iii)           
Executive’s gross negligence or willful misconduct with respect to the Company, including but not limited to dishonesty in
the performance of Executive’s duties hereunder or conversion, misappropriation or embezzlement by Executive of any monies or property
of the Company; or

 

(iv)            
the institution of formal legal charges for, or conviction of Executive of fraud, embezzlement, any other offense involving dishonesty
or constituting a breach of trust, or any felony (or any crime in any jurisdiction other than the United States or any state thereof in
which the Company does business which would constitute such a felony under the laws of the United States or any state thereof).

 

“Code”
means the Internal Revenue Code of 1986, as amended.

 

“Company Board”
means the board of directors of the Company.

 

 

    	 	 	 

     

    

 

“Disability”
means physical or mental incapacity resulting in Executive being unable to perform Executive’s duties for any consecutive 90-day
period, or for any 180 days during any consecutive 12-month period. Any question as to the existence of the Disability of Executive as
to which Executive and the Company cannot agree shall be determined in writing by a qualified independent physician as appointed by the
Company and Executive (or Executive’s representative). The determination of Disability made in writing to the Company and Executive
shall be final and conclusive for all purposes of this Agreement.

 

“Good Reason”
means:

 

(i)                
Any material failure by the Company to comply with any of the provisions of this Agreement or any other agreement between Executive
and the Company pursuant to which Executive provides services, other than an isolated, insubstantial or other failure which can be remedied
and is remedied by the Company within 30 days after the Company’s receipt of written notice thereof from Executive;

 

(ii)             
Executive is assigned duties and responsibilities that represent a material diminution of the duties and responsibilities of the
Position, other than such assignments made with Executive’s written consent;

 

(iii)           
Executive’s Base Salary, as it may be increased from time to time, is decreased materially by the Company on a basis not
shared in common with all other senior executive officers of the Company as a group; or

 

(iv)            
Executive’s principal place of employment is moved more than forty (40) miles from Executive’s current principal place
of employment without Executive’s consent.

 

“Good Reason”
shall not be present unless (1) Executive shall have given the Company written notice specifying in reasonable detail the event or circumstances
constituting Good Reason within 30 days of the occurrence of such event or circumstances, (2) the Company fails to cure such event or
circumstances within thirty (30) days from the date of such notice from Executive and (3) Executive terminates Executive’s
employment within sixty (60) days of the end of the cure period. For purposes of clarification, if the Company cures an incidence of Good
Reason and a subsequent or separate incidence of Good Reason occurs, Executive must comply with all conditions set forth herein for such
separate or subsequent event.

 

2.       Term
of Employment. Subject to the provisions of Sections 5.1 through Section 5.3, inclusive, Executive shall be employed by
the Company for a period commencing on Executive’s first day of employment (the “Start Date”), which is expected
to be on February 6, 2012, and ending on the termination or resignation of Executive (the “Employment Term”). Executive’s
employment is “at will” and can be terminated by the Company or Executive at any time and for any reason, and nothing in this
Agreement shall be construed as an agreement or commitment of employment for any period of time. Upon termination of Executive’s
employment with the Company for any reason, the Company’s obligation to make payments hereunder shall cease, except that the Company
shall be required to make the payments set forth in Section 5 herein.

 

3.       Position.

 

(a)       During
the Employment Term, Executive shall be elected to and shall serve as Chief Executive Officer (the “Position”) and
in the performance of such duties shall report directly to the Company’s Board of Directors. Subject to applicable law and the overall
policy directives of the Company Board, Executive shall have all executive powers and authority which are necessary to enable Executive
to discharge Executive’s duties while serving in the Position and which are commonly incident to such Position consistent with similar
companies of a similar size. Executive will travel from time to time to the extent reasonably necessary to the performance of Executive’s
duties hereunder. Executive shall perform any other duties reasonably required by the Company, and if requested by the Company, shall
serve as an officer or director of the Company or any wholly-owned subsidiary. Executive’s compensation for such additional duties
shall be determined in good faith by the Company Board.

 

 

    	 	2	 

     

    

 

(b)       During
the Employment Term, Executive shall in good faith perform the duties set forth in this Section 3 and shall devote substantially
all of Executive’s working time and efforts to the performance of such duties; provided, however, that Executive may devote time
to personal and family investments, industry related groups and board positions, not for profit boards and other activities to the extent
that such activities do not materially conflict with the discharge of Executive’s duties hereunder. The existence of any such material
conflict shall be determined in good faith by the Company Board.

 

4.       Compensation.

 

4.1.       Base
Salary. The Company shall pay Executive an annual base salary (the “Base Salary”) at the initial gross annual
rate of $260,000, payable in regular installments in accordance with the Company’s usual payment practices but not less frequently
than semi-monthly during the Employment Term. The Company Board, or a compensation committee appointed by the Company Board, shall annually
review the Base Salary and determine changes in the Base Salary.

 

4.2.       Bonus.
With respect to each fiscal year, all or part of which is contained in the Employment Term (including the current fiscal year), Executive
shall be eligible to receive, in addition to Executive’s Base Salary, a cash or stock equivalent bonus (the “Bonus”)
of up to 50% of the Base Salary (“Target Amount”) for services rendered during such fiscal year. For each fiscal year
during the Employment Term, the Bonus will be based upon yearly or quarterly performance criteria (both personal and for the Company),
which will be determined by the Company Board and will be communicated to Executive in writing within sixty (60) days following the start
of the applicable fiscal year; provided, however, that for the current fiscal year, such performance criteria will be provided to Executive
within sixty (60) days of the Start Date. The Bonus will be paid no later than the date that is ninety (90) days following the end of
the fiscal year. Executive must continue to be employed by the Company on the payment date in order to be entitled to receive the Bonus.

 

4.3             
Benefits.

 

(a)       Incentive
Benefits. Executive will be entitled to participate in the Company’s compensation, incentive and benefit plans and arrangements
currently available or which may be made available to senior executives in the future, as amended from time to time, subject to and on
a basis consistent with the terms, conditions and overall administration of such plans and arrangements on the same terms as such benefits
are provided to other senior executives of the Company. The Company, in its discretion, reserves the right to amend or terminate such
benefits at any time.

 

(b)       Welfare
Benefits. The Company shall also provide to Executive all vacation, health, major medical, hospitalization, life insurance and disability
insurance on the same terms as such benefits are provided to other senior executive officers of the Company. The Company, in its discretion,
reserves the right to amend or terminate such benefits at any time.

 

4.4             
Business Expenses and Perquisites. The Company shall promptly reimburse Executive for all out-of-pocket expenses paid by
Executive in connection with the performance of Executive’s duties hereunder pursuant to the Company’s policy for travel and
expense reimbursement. In addition, all reimbursements provided under this Agreement shall be made or provided in accordance with the
requirements of Section 409A of the Code, including, where applicable, the requirement that (i) any reimbursement is for expenses incurred
during Executive’s lifetime (or during a shorter period of time specified in this Agreement); (ii) the amount of expenses eligible
for reimbursement during a calendar year may not affect the expenses eligible for reimbursement in any other calendar year; (iii) the
reimbursement of an eligible expense shall be made no later than the last day of the calendar year following the year in which the expense
is incurred; and (iv) the right to reimbursement or in kind benefits is not subject to liquidation or exchange for another benefit.

 

4.5             
Place of Employment. The principal place of employment of Executive shall be within a 60-mile radius of Boulder, Colorado,
or such other location as is consented to by Executive in writing. It is understood, however, and agreed that Executive may be required,
in connection with the performance of Executive’s duties, to work from time to time at other locations designated by the Company
Board or as required in connection with the business of the Company. When required to travel to and/or spend time at such other locations,
Executive’s reasonable traveling and temporary living expenses shall be reimbursed by the Company, upon submittal of vouchers in
accordance with Section 4.5.

 

 

    	 	3	 

     

    

 

5. Termination. Executive’s
employment may be terminated by either party at any time. In the event of any such termination, the rights of the parties will be determined
as set forth in this Section 5. Executive acknowledges and agrees that any valid written notice of termination by Executive delivered
in accordance with the terms of this Agreement shall operate as a resignation by Executive from the Position.

 

5.1.       Termination
For Cause by the Company. If Executive’s employment is terminated by the Company for Cause or due to Executive’s death
or Disability, (a) Executive shall be entitled to receive Executive’s Base Salary and unpaid accrued vacation through the date
of termination, (b) the Company shall reimburse Executive in accordance with Section 4.5 for expenses Executive has incurred
in the pursuit of Executive’s duties under this Agreement prior to the date of termination, and (c) Executive shall not be entitled
to receive any benefits from and after the date of termination, unless otherwise required by applicable law.

 

5.2.       Termination
of Employment Without Cause by the Company/Termination of Employment for Good Reason by Executive.

 

(a)       If
Executive’s employment is terminated by the Company without Cause, the Company shall provide Executive with thirty (30) days’
written notice of termination setting forth the circumstances surrounding the termination (if any). In the event of such termination,
the Company shall, subject to subsection (c) below, pay Executive:

 

(i) Base Salary earned through
the date of termination;

 

(ii) Base Salary for a period
of nine (9) months following the termination, to be paid on the Company’s regularly scheduled payroll dates commencing within the
first regular payroll date to occur following Executive’s delivery of an effective release of claims as described in Section 5.2(c)
below (the date such release is effective is the “Release Effective Date”); provided, however, that any payments that
would have otherwise been made prior to the Release Effective Date but for the fact that a release had not yet been delivered, shall accrue
and be paid in the first payroll date that follows such Release Effective Date, with subsequent payments occurring on each subsequent
Company payroll date (the “Severance Payments”);

 

(iii) if Executive timely and
properly elects health continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 or any similar state health
insurance continuation program ("COBRA"), Company shall reimburse Executive for the monthly COBRA premium paid by Executive.
Such reimbursement shall be paid to Executive on the fifth (5) day of the month immediately following the month in which Executive timely
remits the premium payment. Executive shall be eligible to receive such reimbursement until the earliest of: (i) the nine (9) month anniversary
of the termination date; (ii) the date Executive is no longer eligible to receive COBRA continuation coverage; and (iii) the date on which
Executive becomes eligible to receive substantially similar coverage from another employer or other source.  Notwithstanding the
foregoing, if Company's making payments under this Section would violate the nondiscrimination rules applicable to non-grandfathered plans
under the Affordable Care Act (the "ACA"), or result in the imposition of penalties under the ACA and the related regulations
and guidance promulgated thereunder), the parties agree to reform this Section in a manner as is necessary to comply with the ACA;

 

(iv) reimbursement for expenses
incurred but not yet reimbursed by the Company in the pursuit of Executive’s duties prior to the date of termination in accordance
with Section 4.5 of this Agreement to be paid within thirty (30) days of such termination;

 

(v) any Bonus earned for a completed
fiscal year but not yet paid to be paid within the earlier of (A) thirty (30) days of such termination and (B) the date that is ninety
(90) days following the end of the fiscal year during which the Bonus is earned;

 

(vi) any other compensation
and benefits to which Executive may be entitled under applicable plans, programs and agreements of the Company to be paid, if applicable,
within thirty (30) days of such termination or earlier if required by applicable law; and

 

(vii) unpaid vacation earned
or accrued through Executive’s date of termination to be paid within thirty (30) days of such termination, or earlier if required
by applicable law.

 

(b)       If
Executive resigns for Good Reason, such resignation shall be treated for all purposes of this Agreement as a termination of Executive’s
employment without Cause.

 

 

    	 	4	 

     

    

 

(c) Any payment by the Company
pursuant to this Section 5.2 is, to the extent permissible under applicable law, conditioned upon the execution and effectiveness (including
the execution of any non-revocation period) of a general release of claims, in a form reasonably satisfactory to the Company in its discretion,
which is to be provided to Executive no later than the date of Executive’s termination of employment with the Company, of the Company,
its Affiliates and any related parties signed by Executive. Such release shall be fully effective no later than sixty (60) days following
termination or Executive shall forfeit the Severance Payments under this Section 5.2.

 

5.3.       Resignation
Without Good Reason. If Executive resigns Executive’s employment with the Company for any reason (other than Good Reason as
provided in Section 5.2 hereof), Executive shall be entitled to the same payments Executive would have received if Executive’s
employment had been terminated by the Company for Cause.

 

5.4.       No
Mitigation or Offset. In the event of any termination of Executive’s employment under this Agreement, Executive shall be under
no obligation to seek other employment, and there shall be no offset against amounts due under this Agreement on account of any remuneration
attributable to any subsequent employment that Executive may obtain.

 

5.5.       Nature
of Payments. Any amounts due Executive under this Agreement in the event of any termination of Executive’s employment with the
Company are in the nature of severance payments, or liquidated damages which contemplate both direct damages and consequential damages
that may be suffered as a result of the termination of Executive’s employment, or both, and are not in the nature of a penalty.

 

5.6.       Notice
of Termination. Any purported termination of employment by the Company or resignation by Executive shall be communicated by written
notice to the other party hereto.

 

6.       Non-Competition:
Non-Solicitation; Non-Disparagement

 

6.1.       Non-Competition.
Executive acknowledges that during Executive’s employment Executive will have access to and knowledge of the Company’s proprietary
information and trade secrets and Executive’s Position is an executive level position in the Company. To protect the Company’s
proprietary information and trade secrets during Executive’s employment with the Company whether full-time or part-time and for
a period of twelve (12) months after the termination date of Executive’s employment with the Company (the “Non-Competition
Period”), Executive will not directly or indirectly engage in (whether as an employee, consultant, proprietor, partner, director
or otherwise), or have any ownership interest in, or participate in the financing, operation, management or control of, any person, firm,
corporation or business that engages in a “Restricted Business” in a “Restricted Territory” (as defined below).
It is agreed that ownership of (i) no more than one percent (1%) of the outstanding voting stock of a publicly traded corporation,
or (ii) any stock Executive presently owns will not constitute a violation of this provision. Executive agrees and acknowledges that
the time limitation on the restrictions in this Section 6, combined with the geographic scope, is reasonable. Executive also acknowledges
and agrees that this Section 6 is reasonably necessary for the protection of the Company’s proprietary information and trade,
that through employment Executive will receive adequate consideration for any loss of opportunity associated with the provisions herein,
and that these provisions provide a reasonable way of protecting the Company’s business value which will be imparted to Executive.
If any restriction set forth in this Section 6 is found by any court of competent jurisdiction to be unenforceable because it extends
for too long a period of time or over too great a range of activities or in too broad a geographic area, it will be interpreted to extend
only over the maximum period of time, range of activities or geographic area as to which it may be enforceable. As used herein, the terms:
(a) “Restricted Business” means any material line of business conducted by the Company during Executive’s
employment with the Company and (b) “Restricted Territory” means any state, county, or locality in the United
States in which the Company conducts business as of the date of termination and any other country, city, state, jurisdiction, or territory
in which the Company does business as of the date of termination.

 

6.2.       Non-Solicitation
& Non-Interference. During the Non-Competition Period, Executive will not (a) directly or indirectly induce any individual
known to Executive to be an employee, independent contractor or consultant of the Company to terminate or negatively alter his or her
relationship with the Company or hire or assist any subsequent employer or Affiliated to hire any such person (b) solicit the business
of any individual or entity known to Executive to be a client or customer of the Company (other than on behalf of the Company) in any
manner that is competitive with the Company or (c) induce any individual or entity known to Executive to be a supplier, content provider,
vendor, consultant or independent contractor of the Company to terminate or negatively alter his, her or its relationship with the Company.
If any restriction set forth in this Section is found by any court of competent jurisdiction to be unenforceable because it extends for
too long a period of time or over too great a range of activities or in too broad a geographic area, it will be interpreted to extend
only over the maximum period of time, range of activities or geographic area as to which it may be enforceable.

 

 

    	 	5	 

     

    

 

6.3.       Non-Disparagement.
Executive and the Company and its Affiliates agree not to disparage the other in any manner likely to be harmful to them or their business
or personal reputation. Notwithstanding the foregoing, nothing in this Agreement shall prohibit any party from (a) making truthful statements
or disclosures required by applicable law, regulation or legal process; (b) requesting or receiving confidential legal advice; (c) engaging
in communications protected under Section 7 of the National Labor Relations Act; (d) responding to inquiries of a prospective employer;
or (e) participating in any investigation by the federal Equal Employment Opportunity Commission, the Department of Labor, or any other
federal, state or local agency.

 

7.       Proprietary
Information. Executive will be required as a condition of employment to sign and abide by the Company’s Employee Proprietary
Information and Inventions Agreement (the “Proprietary Information Agreement”), a form of which is attached hereto
as Exhibit A. Nothing in the Proprietary Information Agreement shall limit or otherwise circumscribe any confidentiality agreement
Executive may have previously entered into with the Company. To the extent there are any conflicts between the terms of this Agreement
and those set forth in the Proprietary Information Agreement, the terms of this Agreement shall prevail and control.

 

8.       Non-Compliance.
Subject to the following sentence, but notwithstanding any other provision of this Agreement to the contrary (specifically including the
provisions of Section 5), if Executive breaches Section 6 or materially breaches the Proprietary Information Agreement while
employed by the Company, the Company may terminate the employment of Executive for Cause, and, whether or not Executive is employed by
the Company, from and after any such breach by Executive, the Company shall cease to have any obligations to make payments to Executive
under this Agreement. The Company shall give Executive written notice of an event or circumstances constituting a breach of Section 6
or the Proprietary Information Agreement and, if Executive establishes the inadvertence of such breach to the reasonable satisfaction
of the Company, Executive shall have 30 days from the date of receipt of such notice to cure such event or circumstances, if curable.

 

9.       Specific
Performance. Executive acknowledges and agrees that the Company’s remedies at law for a breach of any of the provisions of Section 6
hereof would be inadequate and, in recognition of this fact, Executive agrees that, in the event of such a breach, in addition to any
remedies at law, the Company, without posting any bond, shall be entitled to obtain equitable relief in the form of specific performance,
temporary restraining order, temporary or permanent injunction or any other equitable remedy which may then be available.

 

10.       Enforceability.
It is expressly understood and agreed that although Executive and the Company consider the restrictions contained in Section 6
hereof to be reasonable, if a final judicial determination is made by a court of competent jurisdiction that the time or territory or
any other restriction contained in this Agreement is an unenforceable restriction against Executive, the provisions of this Agreement
shall not be rendered void but shall be deemed amended to apply as to such maximum time and territory and to such maximum extent as such
court may judicially determine or indicate to be enforceable. Alternatively, if any court of competent jurisdiction finds that the any
restriction contained in this Agreement is unenforceable, and such restriction cannot be amended so as to make it enforceable, such finding
shall not affect the enforceability of any of the other restrictions contained herein.

 

11.       Key
Man Insurance. The Company may, at its sole cost and expense, secure a policy of Key Man life insurance on the life of Executive,
with death benefits payable to the Company. Executive shall have no right, title or interest in or to such insurance. Executive shall
cooperate with the Company in procuring such insurance by submitting to reasonable examinations and signing such applications or other
instruments as may be required by the insurance carriers with respect to such insurance.

 

12. Indemnification. In
the event that Executive is made a party or threatened to be made a party to any action, suit, or proceeding, whether civil, criminal,
administrative, or investigative (a “Proceeding”), other than any Proceeding initiated by Executive or the Company
related to any contest or dispute between Executive and the Company or any of its affiliates with respect to this Agreement or Executive’s
employment hereunder, by reason of the fact that Executive is or was a director or officer of the Company, or any affiliate of the Company,
or is or was serving at the request of the Company as a director, officer, member, employee, or agent of another corporation or a partnership,
joint venture, trust, or other enterprise, Executive shall be indemnified and held harmless by the Company to the maximum extent permitted
under applicable law and the Company’s bylaws from and against any liabilities, costs, claims, and expenses, including all costs
and expenses incurred in defense of any Proceeding (including attorneys’ fees). Costs and expenses incurred by the Employee in defense
of such Proceeding (including attorneys’ fees) shall be paid by the Company in advance of the final disposition of such litigation
upon receipt by the Company of: (i) a written request for payment; (ii) appropriate documentation evidencing the incurrence, amount, and
nature of the costs and expenses for which payment is being sought; and (iii) an undertaking adequate under applicable law made by or
on behalf of Executive to repay the amounts so paid if it shall ultimately be determined that Executive is not entitled to be indemnified
by the Company under this Agreement. Notwithstanding the foregoing to the contrary in this Section, the Company shall not be required
to indemnify Executive or hold Executive harmless for any gross negligence or intentional misconduct by Executive.

 

 

    	 	6	 

     

    

 

13.       Miscellaneous.

 

13.1. Taxes. Executive
agrees to be responsible for the payment of any taxes due on any and all compensation or benefit provided by the Company pursuant to
this Agreement. Executive agrees to indemnify the Company and hold the Company harmless from any and all claims or penalties asserted
against the Company for any failure to pay taxes due on any compensation or benefit provided by the Company pursuant to this Agreement.
Executive expressly acknowledges that the Company has not made, nor herein makes, any representation about the tax consequences of any
consideration provided by the Company to Executive pursuant to this Agreement. Executive expressly acknowledges that the Company has
not made, nor herein makes, any representation about the tax consequences of any consideration provided by the Company to Executive pursuant
to this Agreement. All forms of compensation referred to in this Agreement are subject to reduction to reflect applicable required withholding
and payroll taxes and other deductions required by law. Executive agrees that the Company does not have a duty to design its compensation
policies in a manner that minimizes Executive’s tax liabilities, and Executive will not make any claim against the Company or the
Company Board related to tax liabilities arising from Executive’s compensation. For purposes of this Agreement, a termination of
employment will be determined consistent with the rules relating to a “separation from service” as defined in Section 409A
of the Code and the regulations thereunder. Notwithstanding anything else provided herein, to the extent any payments provided under
this Agreement in connection with Executive’s termination of employment constitute deferred compensation subject to Section 409A
of the Code, and Executive is deemed at the time of such termination of employment to be a “specified employee” under Section
409A of the Code, then such payment shall not be made or commence until the earlier of (i) the expiration of the 6-month period measured
from Executive’s separation from service from the Company or (ii) the date of Executive’s death following such a separation
from service; provided, however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Executive
including, without limitation, the additional tax for which Executive would otherwise be liable under Section 409A of the Code in the
absence of such a deferral. To the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409A of
the Code, the provision will be read in such a manner so that all payments hereunder comply with Section 409A of the Code. Payments pursuant
to this Agreement are intended to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. Except
as otherwise expressly provided herein, to the extent any expense reimbursement or the provision of any in-kind benefit under this Agreement
is determined to be subject to Section 409A of the Code, the amount of any such expenses eligible for reimbursement, or the provision
of any in-kind benefit, in one calendar year shall not affect the expenses eligible for reimbursement in any other taxable year (except
for any lifetime or other aggregate limitation applicable to medical expenses), in no event shall any expenses be reimbursed after the
last day of the calendar year following the calendar year in which you incurred such expenses, and in no event shall any right to reimbursement
or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit.

 

13.2.       Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Colorado without giving any effect
to any choice or conflict of law provision or rule (whether of the State of Colorado or any other jurisdiction) that would cause the application
of the laws of any jurisdiction other than the State of Colorado.

 

13.3.       Waiver
of Jury Trial. TO THE EXTENT PERMITTED BY LAW, THE PARTIES HERETO EACH WAIVE TRIAL BY JURY IN CONNECTION WITH ANY DISPUTE ARISING
OUT OF OR IN CONNECTION WITH THIS AGREEMENT.

 

13.4.       Entire
Agreement: Amendments. This Agreement contains the entire understanding of the parties with respect to the employment of Executive
by the Company. There are no restrictions, agreements, promises, warranties, covenants or undertakings between the parties with respect
to the subject matter herein other than those expressly set forth herein. This Agreement may not be altered, modified, or amended except
by written instrument signed by the parties hereto.

 

13.5.       No
Waiver. The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered
a waiver of such party’s rights or deprive such party of the right thereafter to insist upon strict adherence to that term or any
other term of this Agreement.

 

13.6.       Severability.
In the event that any one or more of the provisions of this Agreement shall be or become invalid, illegal or unenforceable in any respect,
the validity, legality and enforceability of the remaining provisions of this Agreement shall not be affected thereby.

 

13.7.       Assignment.

 

(a)       Absent
the prior written consent of the Company, this Agreement shall not be assignable by Executive, except that Executive may assign payments
due hereunder to a trust established for the benefit of Executive’s family or to Executive’s estate or to any partnership
or trust entered into by Executive and/or Executive’s immediate family members (meaning, Executive’s spouse, lineal descendants,
parents and siblings).

 

 

    	 	7	 

     

    

 

(b)       Absent
the prior written consent of Executive, this Agreement shall not be assignable by the Company, except that the Company may assign this
Agreement (i) in connection with a sale of substantially all of the assets of the Company or (ii) to an Affiliate.

 

13.8.       Successors:
Binding Agreement. This Agreement shall inure to the benefit of and be binding upon personal or legal representatives, executors,
administrators, successors, heirs, distributees, devisees and legatees of Executive and successors and assigns of the Company.

 

13.9.       Notice.
For the purpose of this Agreement, notices and all other communications provided for in this Agreement shall be in writing and shall be
given to the respective addresses set forth on the execution page of this Agreement, provided that:

 

(a)       all
notices to the Company shall be directed to the attention of Auddia Inc., 2100 Central Avenue, Suite 200, Boulder, CO 80301, Attn: Jeffrey
Thramann, with a copy to James Carroll, Carroll Legal LLC, 233 McKinley Park Lane, Louisville, CO 80027.

 

(b)       all
notices to Executive shall be directed to Michael Lawless, 4383 Scarsdale Place, Boulder, CO 80301, with a copy to Christina McGarr at
Savrick, Schumann, Johnson, McGarr, Kaminski & Shirley, LLP at 250 Arapahoe Avenue, Suite 301, Boulder, CO 80302.

 

or to such other address as either party may have
furnished to the other in writing in accordance herewith. Each such notice or other communication shall be effective (i) if given
by prepaid overnight courier, upon receipt, (ii) if given by United States mail, postage prepaid, return receipt requested, the later
of actual receipt or three business days after deposit with the United States postal service, or (iii) upon confirmed receipt of email;
provided that notice of change of address shall be effective only upon receipt.

 

13.10.       Withhold
Taxes. The Company may withhold from any amounts payable under this Agreement such Federal, state and local taxes as may be required
to be withheld pursuant to any applicable law or regulation.

 

13.11.       Counterparts.
This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and
hereto were upon the same instrument.

 

[SIGNATURE PAGES FOLLOW]

 

 

    	 	8	 

     

    

 

IN WITNESS WHEREOF, the parties
have executed this Employment Agreement as of the date first above written.

 

COMPANY:

 

Auddia Inc.

 

 

By:  /s/
Jeffrey J.
Thramann                                                   
 

Jeffrey J. Thramann 

Executive Chairman 

 

 

EXECUTIVE: 

 

 

/s/ Michael
Lawless                                                                  

Michael Lawless 

Chief Executive Officer

 

 

 

 

    	 	 	 

     

    

  

Exhibit A

 

Proprietary Information Agreement

 

 

[to be attached]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]